Days at home alive after major surgery in patients with and without diabetes: an observational cohort study.

ABSTRACT:

Objective

We hypothesized that days at home alive up to 30 days after surgery (DAH30), a novel patient-centered outcome metric, as well as long-term mortality, would be impaired in patients with type 1 or 2 diabetes mellitus (DM) undergoing major surgery.

Methods

This cohort study investigated patients > 18 years with and without DM presenting for major non-cardiovascular, non-ambulatory surgical procedures at 23 hospitals in Sweden between 2007 and 2014. We identified 290,306 patients. Data were matched with various quality registers. The primary outcome was the composite score, DAH30. The secondary outcome was mortality from 31 to 365 days. Using multivariable logistic regression, significant independent risk factors influencing the primary and secondary outcomes were iden

SUBMITTER: Habermann A 

PROVIDER: S-EPMC10802053 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature